Search

Search Constraints

You searched for: Author/Creator Andrikopoulou, Angeliki

Search Results

2. 2022-RA-1607-ESGO Optimal time interval between neoadjuvant platinum-based chemotherapy and interval debulking surgery. (20th October 2022)

3. Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer. Issue 4 (5th January 2023)

5. SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors. (December 2021)